SPOTLIGHT -
Ms Kuntz is the assistant managing editor of Psychiatric Times.
APhA Conference Addresses Depression, Benzos
Catch up on all the latest from the American Pharmacists Association (APhA) Annual Meeting & Exposition.
Naloxone as a Tool to Fight the Opioid Epidemic
If you missed out on the custom Around the Practice video program on naloxone, we've got you covered. Read a recap here.
Hyperprolactinemia and Antipsychotic Therapy in Patients With Schizophrenia
A recent study examined hyperprolactinemia and antipsychotic therapy in patients with schizophrenia and Hashimoto's thyroiditis.
New Approval for Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder
The FDA has approved dexmedetomidine sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Predicting Depression and Alzheimer Disease Through Major Depressive Disorder Risk Factors
Individuals with depression may be at a greater risk to develop late-onset Alzheimer disease, but a new study suggests depression onset may help predict Alzheimer disease.
Psychiatric Care in the US: Are We Facing a Crisis?
What US state has the best mental health care?
World Bipolar Day: The Birthday of Vincent Van Gogh
Today is World Bipolar Day! Celebrate with the freshest clinical pearls on bipolar disorder that Psychiatric Times has to offer.
Too Risky? Mental Illness and Risky Behaviors During the COVID-19 Pandemic
Patients with bipolar I disorder and other mental illnesses may be at increased risk for COVID-19 infection.
Building a Connection: Telehealth for PTSD and Bipolar Disorder Treatment
Two forms of telehealth can improve quality of life and care for patients with PTSD and bipolar disorder who live in more rural communities.
The First and Only Transdermal Patch for Alzheimer Disease
This donepezil transdermal system helps with the treatment on mild, moderate, or severe dementia of the Alzheimer type.
Taking a Look at Child Athlete Mental Health
Is the mental health of young athletes in danger?
Research Roundup: Psychiatric Comorbidities in the News
Catch up on all the latest in psychiatric comorbidities.
TikTok: Biggest Concerns for Children and Adolescents
TikTok: How is it harming child and adolescent mental health?
Fun and Games: Improving Youth Opioid Awareness
Can a game improve children and adolescents knowledge of the opioid crisis?
A Consequence of Health Disparities: Depression Among Sexual Minorities
According to this study examining sexual minority patients, depression can be a consequence of health and behavioral disparities.
The Blueprint: Strategizing and Partnering to End Youth Suicide
The Chief Medical Officer for the AFSP sat down with Psychiatric Times to talk about the new Blueprint for Youth Suicide Prevention.
Concerning Content: TikTok’s Effect on Child and Adolescent Mental Health
TikTok has over 1 billion users and dominates youth culture. But is it damaging their mental health?
The Relationship Between MDD and Lower Vitamin D Levels in Women
Are lower vitamin D levels in women related to depressive mood?
Before the Toils of War: Mental Health in Ukraine
The mental health of Ukrainians is essential, now more than ever.
Acknowledging the Great Women in Our Lives
What woman inspires you?
Study Intends to Find New Ways to Treat or Prevent Major Depression
Investigators have launched a 3-year study to develop predictive models that will help identify better treatment plans for patients with depression.
Need Your Sleep: DTx for Treating Comorbid Insomnia and Psychiatric Disorders
Digital therapeutics may be poised to step up as the next CBT.
Spotlight on Issues in ADHD
Catch up on all the latest in ADHD from the APSARD virtual 2022 Annual Meeting.
The Heart of Psychiatry
For American Heart Month, catch up on all the latest in psychocardiology.
Improving Depression Symptoms: Study Meets Endpoints
A new study showed zuranolone treatment in patients with major depressive disorder demonstrates a rapid and statistically significant reduction in depressive symptoms.
Goldwater Rule: Change or Stay?
The conversation on the Goldwater Rule is taking place now. Don't miss out on the latest in the debate.
Levounis Named APA President Elect
Petros Levounis, MD, MA, has been chosen to lead the APA by his fellow members.
Antipsychotics and Weight Gain: Positive Study Results
Alkermes announced positive results from their phase 3b ENLIGHTEN-Early study.
Sleepy Link: Sleep, Depression, & Bipolar Disorder in Children and Adolescents
Sleep, depression, and bipolar disorder: what's the connection?
First of Its Kind Study of Antidepressant Use in Comorbid Depression and Type 2 Diabetes Mellitus
Effective treatment of depression in individuals with comorbid depression and type 2 diabetes mellitus is important for both conditions.